Published in Biochim Biophys Acta on April 17, 1990
Scavenger receptor class B, type I (SR-BI) is the major route for the delivery of high density lipoprotein cholesterol to the steroidogenic pathway in cultured mouse adrenocortical cells. Proc Natl Acad Sci U S A (1997) 1.34
Lipid utilization by human lymphocytes is correlated with high-density-lipoprotein binding site activity. Biochem J (1992) 0.90
New developments in selective cholesteryl ester uptake. Curr Opin Lipidol (2013) 0.85
A high-density-lipoprotein receptor appears to mediate the transfer of essential fatty acids from high-density lipoprotein to lymphocytes. Biochem J (1992) 0.80
Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus. Hepatology (2001) 2.71
Characterization of muscarinic receptors on guinea pig gallbladder smooth muscle. Gastroenterology (1993) 2.05
Apolipoprotein B mRNA editing in 12 different mammalian species: hepatic expression is reflected in low concentrations of apoB-containing plasma lipoproteins. J Lipid Res (1993) 1.93
Oxygen consumption and resting metabolic rate in sepsis, sepsis syndrome, and septic shock. Crit Care Med (1993) 1.48
Dietary fish oil lowers lipoprotein(a) in primary hypertriglyceridemia. Atherosclerosis (1991) 1.42
[Pravastatin for older patients with risk of vascular disease. The PROSPER-Study]. Internist (Berl) (2003) 1.39
Binding of rat chylomicrons and their remnants to the hepatic low-density-lipoprotein receptor and its role in remnant removal. Biochem J (1988) 1.32
Stress-induced gastrointestinal secretory and motor responses in rats are mediated by endogenous corticotropin-releasing factor. Gastroenterology (1988) 1.32
Function of hepatic triglyceride lipase in lipoprotein metabolism. J Lipid Res (1981) 1.15
A new mechanism of exogenous hyperglyceridemia. Ann Intern Med (1969) 1.11
Central nervous system effects of corticotropin-releasing factor on gastrointestinal transit in the rat. Gastroenterology (1988) 1.08
Measurement of two plasma triglyceride lipases by an immunochemical method: studies in patients with hypertriglyceridemia. J Lipid Res (1976) 1.07
Hepatitis B virus genomes of patients with fulminant hepatitis do not share a specific mutation. Hepatology (1996) 1.05
Amelioration of hypertriglyceridaemia by progestational drugs in familial type-V hyperlipoproteinaemia. Lancet (1969) 1.05
Severe myelitis following infection with Campylobacter enteritis. Eur J Clin Microbiol Infect Dis (2004) 1.02
Studies on lipolytic activities of rat liver lysosomes. Hoppe Seylers Z Physiol Chem (1967) 1.00
Monoclonal antibody defines CA 19-9 in pancreatic juices and sera. Gut (1985) 0.98
In vivo metformin treatment ameliorates insulin resistance: evidence for potentiation of insulin-induced translocation and increased functional activity of glucose transporters in obese (fa/fa) Zucker rat adipocytes. Endocrinology (1993) 0.98
Evidence for separate monoglyceride hydrolase and triglyceride lipase in post-heparin human plasma. J Lipid Res (1969) 0.98
Selective deficiency of hepatic triglyceride lipase in uremic patients. N Engl J Med (1977) 0.98
Acquired type I hyperlipoproteinemia with systemic lupus erythematosus, dysglobulinemia and heparin resistance. Am J Med (1969) 0.97
Purification from human plasma of a heparin-released lipase with activity against triglyceride and phospholipids. J Biol Chem (1975) 0.97
Characterization of CA 19-9 bearing mucins as physiological exocrine pancreatic secretion products. Cancer Res (1986) 0.96
Metformin increases glucose transporter protein and gene expression in human fibroblasts. Biochem Biophys Res Commun (1993) 0.95
Purification, characterization and molecular cloning of human hepatic lysosomal acid lipase. Eur J Biochem (1994) 0.95
Gastrin/cholecystokinin type B receptors in the kidney: molecular, pharmacological, functional characterization, and localization. Eur J Clin Invest (1998) 0.94
Asymptomatic HIV infection is characterized by rapid turnover of HIV RNA in plasma and lymph nodes but not of latently infected lymph-node CD4+ T cells. AIDS (1997) 0.94
Donor splice site mutation in the apolipoprotein (Apo) C-II gene (Apo C-IIHamburg) of a patient with Apo C-II deficiency. J Clin Invest (1988) 0.93
Antiproliferative effects exerted by recombinant human tumor necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma) on human pancreatic tumor cell lines. Pancreas (1988) 0.93
Annexin VI, a marker protein of hepatocytic endosomes. J Biol Chem (1994) 0.93
A comparative study of post-heparin lipolytic activity and a purified human plasma triacylglycerol lipase. Biochim Biophys Acta (1974) 0.92
Inhibition of the apolipoprotein B mRNA editing enzyme-complex by hnRNP C1 protein and 40S hnRNP complexes. Biol Chem (1998) 0.92
Modulation of platelet-derived growth factor A- and B-chain/c-sis mRNA by tumor necrosis factor and other agents in adenocarcinoma cells. Oncogene (1991) 0.92
In vivo activated peripheral T cells in autoimmune disease. J Clin Lab Immunol (1986) 0.91
Monoclonal antibody-defined human pancreatic cancer-associated antigens. Cancer Res (1985) 0.90
Hepatitis B virus sequence changes evolving in liver transplant recipients with fulminant hepatitis. J Hepatol (1997) 0.90
Lipoprotein lipase mediates an increase in the selective uptake of high density lipoprotein-associated cholesteryl esters by hepatic cells in culture. J Lipid Res (1998) 0.89
Purification of rat adipose tissue lipoprotein lipase. FEBS Lett (1973) 0.89
The human asialoglycoprotein receptor is a possible binding site for low-density lipoproteins and chylomicron remnants. Biochem J (1991) 0.89
Selective uptake of low-density lipoprotein-associated cholesteryl esters by human fibroblasts, human HepG2 hepatoma cells and J774 macrophages in culture. Biochim Biophys Acta (1995) 0.88
Regulation of the hepatic removal of chylomicron remnants and beta-very low density lipoproteins in the rat. J Lipid Res (1992) 0.88
Cellular uptake of lipoprotein[a] by mouse embryonic fibroblasts via the LDL receptor and the LDL receptor-related protein. J Lipid Res (1997) 0.87
Secondary hypertriglyceridaemia in patients with parenchymal liver disease. Eur J Clin Invest (1977) 0.87
Expression of type III hyperlipoproteinemia in patients homozygous for apolipoprotein E-2 is modulated by lipoprotein lipase and postprandial hyperinsulinemia. J Mol Med (Berl) (1998) 0.87
Pneumococcal parotitis and cervical lymph node abscesses in an HIV-infected patient. Clin Investig (1994) 0.87
Lipoproteins and lipolytic plasma enzymes in a case of tangier disease. N Engl J Med (1974) 0.87
Correlation of apolipoprotein(a) isoproteins with Lp(a) density and distribution in fasting plasma. Atherosclerosis (1992) 0.87
Functional analysis of HBV genomes from patients with fulminant hepatitis. Hepatology (1998) 0.87
Selective association of lipoprotein cholesteryl esters with liver plasma membranes. Biochim Biophys Acta (1993) 0.87
Disseminated Mycobacterium genavense infection as a cause of pseudo-Whipple's disease and sclerosing cholangitis. Clin Infect Dis (1997) 0.86
Visceral leishmaniasis in an HIV-infected patient: clinical features and response to treatment. Klin Wochenschr (1991) 0.86
Treatment of disseminated Mycobacterium genavense infection. AIDS (1995) 0.85
Neonatal fulminant hepatitis B: structural and functional analysis of complete hepatitis B virus genomes from mother and infant. J Infect Dis (1998) 0.85
Disseminated cryptococcosis in a patient with AIDS. Mycoses (1995) 0.85
Differences in the mechanisms of uptake and endocytosis of small and large chylomicron remnants by rat liver. Hepatology (1996) 0.85
The effect of polyunsaturated phosphatidylcholine on plasma lipids and fecal sterol excretion. Atherosclerosis (1980) 0.85
[Metabolic diseases and idiopathic ischemic necrosis of the femoral head in adults (author's transl)]. Z Orthop Ihre Grenzgeb (1978) 0.84
The prognostic value of hypocholesterolemia in hospitalized patients. Clin Investig (1994) 0.84
Familial lipoprotein lipase and apolipoprotein C-II deficiency. Lipoprotein and apoprotein analysis, adipose tissue and hepatic lipoprotein lipase levels in seven patients and their first degree relatives. Atherosclerosis (1983) 0.84
Apolipoprotein E isoforms and rare mutations: parallel reduction in binding to cells and to heparin reflects severity of associated type III hyperlipoproteinemia. J Lipid Res (1995) 0.84
Early diagnosis of familial type II hyperlipoproteinemia. Nutr Metab (1973) 0.83
Rotavirus antigen detection in patients with HIV infection and diarrhea. Scand J Gastroenterol (1993) 0.83
Pathways mediating CRF-induced inhibition of gastric acid secretion in rats. Am J Physiol (1989) 0.83
Absence of APOBEC-1 mediated mRNA editing in human carcinomas. Oncogene (1999) 0.83
Analysis of the uncoupling protein-1 (UCP1) gene in obese and lean subjects: identification of four amino acid variants. Int J Obes Relat Metab Disord (1998) 0.83
Lipoprotein lipase mediates an increase in selective uptake of HDL-associated cholesteryl esters by cells in culture independent of scavenger receptor BI. J Lipid Res (2001) 0.83
Missense variants in the human peroxisome proliferator-activated receptor-gamma2 gene in lean and obese subjects. Eur J Endocrinol (1999) 0.82
CRF initiates biological actions within the brain that are observed in response to stress. Am J Physiol (1987) 0.82
Quantitative determination of apolipoprotein A-I in high-density lipoproteins and 'free' apolipoprotein A-I by two-dimensional agarose gel lipoprotein-'rocket' immunoelectrophoresis of human serum. Biochim Biophys Acta (1986) 0.82
Further aspects on the characterization of high and very low density lipoproteins in patients with liver disease. Eur J Clin Invest (1972) 0.82
Mycobacterium kansasii infection limited to skin and lymph node in a patient with AIDS. Clin Exp Dermatol (1990) 0.82
A further characterization of lipoprotein lipase. Biochim Biophys Acta (1968) 0.82
A case of disseminated Mycobacterium bovis infection in an AIDS patient. Eur J Clin Microbiol Infect Dis (1995) 0.82
Biotinyl-high-density lipoproteins as a probe for the determination of high-density lipoprotein turnover in humans. Biochim Biophys Acta (1990) 0.82
Effects of neuropeptides on gastric acid and duodenal bicarbonate secretions in freely moving rats. Regul Pept (1989) 0.81
Apolipoprotein C-II deficiency syndrome due to apo C-IIHamburg: clinical and biochemical features and HphI restriction enzyme polymorphism. Eur J Clin Invest (1992) 0.81
[CA 12-5 in cancer of the digestive tract. A comparison with CA 19-9 and CEA in cancer of the pancreas and colon]. Dtsch Med Wochenschr (1984) 0.81
Rapid decay of HIV RNA in the cerebrospinal fluid during antiretroviral combination therapy. AIDS (1997) 0.81
A 5' splice-region mutation and a dinucleotide deletion in the lysosomal acid lipase gene in two patients with cholesteryl ester storage disease. J Lipid Res (1995) 0.81
Selective uptake of high-density lipoprotein-associated cholesteryl esters and high-density lipoprotein particle uptake by human monocyte-macrophages. Atherosclerosis (1994) 0.81
Lipoprotein lipase compensates for the defective function of apo E variants in vitro by interacting with proteoglycans and lipoprotein receptors. Atherosclerosis (1999) 0.81
Different missense mutations in histidine-108 of lysosomal acid lipase cause cholesteryl ester storage disease in unrelated compound heterozygous and hemizygous individuals. Hum Mutat (1998) 0.81
VNTR polymorphism in the hepatic lipase gene (LIPC). Nucleic Acids Res (1991) 0.80
Purification of human plasma lipoprotein lipase. Biochim Biophys Acta (1980) 0.80
Evidence for CCK(B) receptors in the guinea-pig kidney: localization and characterization by [125I]gastrin binding studies and by RT-PCR. Naunyn Schmiedebergs Arch Pharmacol (1998) 0.80
Influence of lysophosphatidylcholine on the C-apolipoprotein content of rat and human triglyceride-rich lipoproteins during triglyceride hydrolysis. J Clin Invest (1986) 0.80
Opposite effects of insulin and catecholamines on LDL-receptor activity in human mononuclear leukocytes. Diabetes (1988) 0.80
The prostacyclin analogue iloprost and prostaglandin E1 suppress sterol synthesis in freshly isolated human mononuclear leukocytes. Biochim Biophys Acta (1985) 0.80
Interactions of aromatic amino acids with gastric secretagogues in humans. Gastroenterology (1988) 0.80
Distinct promoters induce APOBEC-1 expression in rat liver and intestine. Arterioscler Thromb Vasc Biol (1998) 0.79
In vitro modulation of the distribution of normal human plasma high density lipoprotein subfractions through the lecithin: cholesterol acyltransferase reaction. Biochim Biophys Acta (1982) 0.79
Apolipoprotein E and lipoprotein lipase co-ordinately enhance binding and uptake of chylomicrons by human hepatocytes. Eur J Clin Invest (1995) 0.79
A new model of primary human adipocytes reveals reduced early insulin signalling in type 2 diabetes. Horm Metab Res (2004) 0.79
Apo E-containing lipoproteins in low or high density lipoprotein deficiency. Arteriosclerosis (1985) 0.79
Hepatic lipase mediates an increase in selective uptake of high-density lipoprotein-associated cholesteryl esters by human Hep 3B hepatoma cells in culture. Atherosclerosis (1998) 0.79
Missense variants in the human cholecystokinin type A receptor gene: no evidence for association with early-onset obesity. Horm Metab Res (1999) 0.78
Lysosomal acid lipase. Assay and purification. Methods Mol Biol (1999) 0.78
Blastocystis hominis in human immunodeficiency virus-related diarrhea. Scand J Gastroenterol (1995) 0.78
Secondary type II hyperlipoproteinemia in patients with anorexia nervosa. Metabolism (1978) 0.78